Selective blockade of N-type calcium channels by levetiracetam

Epilepsia

Volumn 43, Issue 1, 2002, Pages 9-18

  Lukyanetz, E A ^a   Shkryl, V M ^a   Kostyuk, P G ^a  

^a BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

Author keywords

Antiepileptic drugs; Calcium channels; Epilepsy; Hippocampal neurons; Levetiracetam

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; ETIRACETAM; GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ANTICONVULSANT THERAPY; ARTICLE; CALCIUM CURRENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; NERVE CELL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; STEADY STATE;

ANIMALS; ANTICONVULSANTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, N-TYPE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; EPILEPSY; HIPPOCAMPUS; KINETICS; NEURONS; NIFEDIPINE; OMEGA-CONOTOXIN GVIA; PATCH-CLAMP TECHNIQUES; PIRACETAM; RATS; RATS, WISTAR;

EID: 0036193683     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2002.24501.x     Document Type: Article

References (59)

1. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy
2. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy
3. Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs
4. Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents
5. Levetiracetam had no effect on low-voltage-activated Ca2+ current in rat CA1 hippocampal neurons
6. Levetiracetam: Modulation of high voltage-activated Ca2+ current in CA1 pyramidal neurons of rat hippocampal slices
7. Levetiracetam inhibits the high-voltage-activated Ca2+ current in pyramidal neurones of rat hippocampal slices
8. High-threshold calcium channel activity in rat hippocampal neurones during hypoxia
9. Vibrodissociation of sliced mammalian nervous tissue
10. Voltage-dependent modulation of N-type calcium channels by G-protein beta gamma subunits
11. Modulation of Ca2+ channels by G-protein beta gamma subunits
12. Three types of neuronal calcium channel with different calcium agonist sensitivity
13. Classes of calcium channels in vertebrate cells
14. Removal of extracellular calcium after conditioning stimulation disrupts long-term potentiation in the CA1 region of rat hippocampal slices
15. Molecular and functional diversity of voltage-gated calcium channels
16. Calcium channels in vertebrate cells
17. Omega-conotoxin-sensitive voltage-operated calcium channels in vertebrate cells
18. Molecular diversity of voltage-dependent Ca2+ channels
19. N- and L-type calcium channel involvement in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells
20. The use of invertebrate peptide toxins to establish Ca2+ channel identity of CA3-CA1 neurotransmission in rat hippocampal slices
21. Different localizations and functions of L-type and N-type calcium channels during development of hippocampal neurons
22. Preferential interaction of omega-conotoxins with inactivated N-type Ca2+ channels
23. Binding of omega-conotoxin to receptor sites associated with the voltage-sensitive calcium channel
24. Characterization of the binding of omega-conopeptides to different classes of non-L-type neuronal calcium channels
25. Localization and functional properties of a rat brain alpha 1A calcium channel reflect similarities to neuronal Q- and P-type channels
26. Distinctive biophysical and pharmacological properties of class A (BI) calcium channel alpha 1 subunits
27. Identification of calcium channels involved in neuronal injury in rat hippocampal slices subjected to oxygen and glucose deprivation
28. New anti-epileptic drugs
29. An assessment of levetiracetam as an anti-epileptic drug
30. Levetiracetam: A review of its adjunctive use in the management of partial onset seizures
31. Expanding first-line therapy options for children with partial seizures
32. Clinical pharmacology of new antiepileptic drugs
33. Treatment of epilepsy in the multiply handicapped
34. Enzyme induction and inhibition by new antiepileptic drugs: A review of human studies
35. New antiepileptic drugs and non-pharmacological treatments
36. Pilocarpine-induced epileptiform activity of isolated CA1 hippocampal neurones
37. Investigation of pilocarpine action on properties of accommodation in isolated phasic neurones of rat hippocampus
38. Interaction between G proteins and accessory subunits in the regulation of 1B calcium channels in Xenopus oocytes
39. Cross-talk between G-protein and protein kinase C modulation of N-type calcium channels is dependent on the G-protein beta subunit isoform
40. The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes
41. Structure and regulation of voltage-gated Ca2+ channels
42. The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata
43. Calcium channels involved in the inhibition of acetylcholine release by presynaptic muscarinic receptors in rat striatum
44. Lamotrigine inhibits Ca2+ currents in cortical neurons: Functional implications
45. Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones
46. Lamotrigine inhibits depolarization-evoked Ca++ influx in dissociated amygdala neurons
47. Kindling induces a long-term enhancement in the density of N-type calcium channels in the rat hippocampus
48. Omega-conotoxin: Direct and persistent blockade of specific types of calcium channels in neurons but not muscle
49. Structural determinants of the blockade of N-type calcium channels by a peptide neurotoxin
50. Omega Conus geographus toxin: A peptide that blocks calcium channels
51. Structure-activity relationships of omega-conotoxins at N-type voltage-sensitive calcium channels
52. Structure-activity analysis of a conus peptide blocker of N-type neuronal calcium channels
53. Antagonists of neuronal calcium channels: Structure, function, and therapeutic implications
54. Calcium channel diversity and neurotransmitter release: The omega-conotoxins and omega-agatoxins
55. Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes
56. Altered expression and assembly of N-type calcium channel alpha1B and beta subunits in epileptic lethargic (1h/1h) mouse
57. Mutation of the Ca2+ channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (1h) mouse
58. Differential expression and association of calcium channel alpha1B and beta subunits during rat brain ontogeny
59. Differential expression and association of calcium channel subunits in development and disease